MedTrace Logo

Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis

NCT02582086 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-03-09

No results posted yet for this study

Summary

The aim of this study is to determine the safety and efficacy of a topical natural health product in comparison to placebo for the treatment of herpes labialis.

Conditions

  • Herpes Labialis

Interventions

OTHER

BOR15001L7

Active cream with 5% 15019L0

OTHER

Placebo

Placebo Cream with 0% 15019L0

Sponsors & Collaborators

  • Laboratoire Boreaderme Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02582086 on ClinicalTrials.gov